Robert Infarinato

Executive Officer, Promoter at Phio Pharmaceuticals.

Raised on Phio Pharmaceuticals filings

$2.3M

of $46.1M offered across 5 Form D filings

Form D filings: 5
Teammates: 7
Last filing: Nov 12, 2025

Company

Phio Pharmaceuticals

Biotech · Marlborough, MA

Immune-modulating cancer drugs in clinical trials

Immune-modulating cancer drugs in clinical trials

Investors: 4
Still open: $43.8M

Investors: 4
Sector: Biotech
HQ: Marlborough, MA

Phio Pharmaceuticals filings

Phio Pharmaceuticals Form D filings
Filed	Security	Sold of offered	Filing
Nov 12, 2025	Security to be acquired	$1.4M/ $25.9M	Form D
Aug 4, 2025	Security to be acquired	$232K/ $5.1M	Form D
Jan 28, 2025	Security to be acquired	$266K/ $6.4M	Form D
Jan 28, 2025	Security to be acquired	$208K/ $5M	Form D
Jan 28, 2025	Security to be acquired	$153K/ $3.7M	Form D

Security to be acquiredFiled Nov 12, 2025Form D
$1.4M/ $25.9M
Security to be acquiredFiled Aug 4, 2025Form D
$232K/ $5.1M
Security to be acquiredFiled Jan 28, 2025Form D
$266K/ $6.4M
Security to be acquiredFiled Jan 28, 2025Form D
$208K/ $5M
Security to be acquiredFiled Jan 28, 2025Form D
$153K/ $3.7M

Works with

Also named on Phio Pharmaceuticals filings

Robert J. BittermanPresident and Chief Executive Officer, Form D signerForm D signer David DemingDirector Lisa CarsonExecutive Officer Robert FerraraDirector Patricia A. BradfordDirector Curtis Lockshin, Ph.D.Director Jonathan FreemanDirector